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Protein–ligand interactionThe hydrophobic cavity of lipocalin-type prostaglandin D synthase (L-PGDS) has been suggested to
accommodate various lipophilic ligands through hydrophobic effects, but its energetic origin
remains unknown. We characterized 18 buffer-independent binding systems between human L-
PGDS and lipophilic ligands using isothermal titration calorimetry. Although the classical hydropho-
bic effect was mostly detected, all complex formations were driven by favorable enthalpic gains.
Gibbs energy changes strongly correlated with the number of hydrogen bond acceptors of ligand.
Thus, the broad binding capability of L-PGDS for ligands should be viewed as hydrophilic interac-
tions delicately tuned by enthalpy–entropy compensation using combined effects of hydrophilic
and hydrophobic interactions.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The intermolecular interactions of macromolecules with part-
ner molecules represent some of the most fundamental biological
processes that include substrate recognition of enzymes, anti-
gen–antibody reactions, and signal transductions [1,2]. To date,
several key binding models have been suggested to obtain a gen-
eral understanding of intermolecular binding mechanisms: the
lock and key model, induced ﬁt model, and conformational selec-
tion (pre-existing) model [3,4]. These models have complementa-
rily explained various intermolecular interactions based on the
static structural shapes and dynamic conformations of interacting
sites. However, they have not yet been elucidated in detail molec-ular origins and mechanisms from a thermodynamic viewpoint.
The thermodynamic characterization of binding systems is critical
because the formation of all complexes is governed by an energetic
balance toward a more favorable state by decreasing the Gibbs en-
ergy change (DG) [5], which is often difﬁcult to observe using only
structure-based approaches. The driving forces for binding have
been simply expressed by two terms: an enthalpy change (DH)
and entropy change (DS) in the equilibrium system [6,7]. Enthalpy
is an excellent reporter of changes in intermolecular contacts such
as electrostatic interactions among charges and/or dipoles, hydro-
gen bonds, and van der Waals’ interactions [2,8,9]. On the other
hand, entropy changes come from the dehydration and change in
molecular ﬂexibility as a result of altering the degree of freedom
of a system [2,10]. Enthalpy and entropy changes occur concomi-
tantly and enthalpy–entropy compensation has been shown to
limit binding afﬁnity [6,11]. Furthermore, these driving forces sen-
sitively reﬂect even subtle changes in molecular conformations
and hydrational states or interactions with ions [12–14]. Therefore,
isothermal titration calorimetry (ITC) is a powerful approach to ex-
plore intermolecular interactions due to the direct and precise
observation of binding enthalpy [1].
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characterizing intermolecular interactions using ITC. We recently
performed in vitro binding studies of human lipocalin-type prosta-
glandin (PG) D synthase (L-PGDS, prostaglandin-H2 D-isomerase,
EC 5.3.99.2) using the tryptophan ﬂuorescence quenching, TNS
competition assay and ITC [15]. Spectroscopic studies revealed that
Human L-PGDS could bind to a large range of lipophilic binding
partners, including heme metabolites, retinoids, thyroids, steroids,
ﬂavonoids, and saturated fatty acids, which differ in molecular size
and physico-chemical properties [15]. In addition, ITC results
showed that L-PGDS bound to two molecules of heme metabolites
such as hemin, biliverdin, and bilirubin with high and low afﬁnities
[15]. We previously proposed that the two-molecules capturing
abilities of L-PGDS for heme metabolites may play an important
role in inhibiting the onset of the delayed cerebral vasospasms in
patients with subarachnoid hemorrhage [15,16]. Hence, the capa-
bility of L-PGDS to bind with various lipophilic ligands is suitable
for ITC-based thermodynamic surveys.
L-PGDS is known to be a multi-functional protein that acts as a
PGD2-producing enzyme [17,18], active oxygen scavenger [19,20],
and secretory transporter protein for small lipophilic molecules
[21]. L-PGDS is also a member of the lipocalin superfamily; lipoca-
lins are small globular proteins of approximately 200 amino acid
residues [22–24] that play a role in the storage and transport of
small lipophilic molecules such as vitamins and fatty acids [25].
Using these properties of L-PGDS, we recently proposed that the
drug delivery system of L-PGDS as a delivery vehicle could facili-
tate the pharmaceutical development and clinical usage of various
water-insoluble compounds [26]. L-PGDS has a typical lipocalin
fold that consists of an eight-stranded anti-parallel b-barrel that
forms a hydrophobic cavity and long a-helix [23,27], and the
hydrophobic cavity encloses the binding sites for small lipophilic
ligands [28,29] (Fig. 1A). It has been widely accepted that L-PGDS
and other lipocalins take advantage of their hydrophobic cavities
to capture lipophilic ligands using hydrophobic interactions. The
classical hydrophobic effects due to the dehydration of water mol-
ecules surrounding the protein and ligand to bulk have been sug-
gested to dominate the binding of lipophilic ligands in the
hydrophobic cavity [30,31]. Although entropy-driven complex
formation between L-PGDS and small lipophilic ligands is ex-
pected, systematic thermodynamic investigations have not yet
been conducted.
To elucidate the relative contributions of driving forces to inter-
molecular interactions, we investigated the ITC-based thermody-
namics of 18 binding systems of L-PGDS with 15 variations of
ligands (retinoic acids, L-thyroxine, progesterone, genistein, and
PGH2-analog U-46619) including the 3 heme metabolites (hemin,
biliverdin, and bilirubin) previously studied [15]. The results
showed that the formation of all complexes was driven by enthal-
py mainly due to intermolecular hydrogen bonding, and not al-
ways by entropic gains such as the typical concept of the
hydrophobic effect. In addition, we proposed that the broad bind-
ing capability of L-PGDS resulted from the delicate balance
achieved by enthalpy and entropy compensation through hydro-
philic and hydrophobic interactions.2. Materials and methods
2.1. Chemicals
Bilirubin, all-trans retinoic acid, 9-cis retinoic acid, and cortico-
sterone were purchased from Wako. Hemin, L-thyroxine (T4),
3,30,5-triiodo-L-thyronine (T3), progesterone, genistein, and daidz-
ein were obtained from Sigma. Biliverdin, testosterone, naringenin,
U-46619, and 2-(p-toluidinyl) naphthalene-6-sulfonic acid (TNS)were purchased from MP Biomedicals, Fluka, Chroma Dex, Cayman
Chemical, and Invitrogen, respectively. All ligands were dissolved
in dimethyl sulfoxide (DMSO). The concentrations of hemin, bili-
verdin, bilirubin, T4, T3, and TNS in DMSO were determined spec-
troscopically with a molar extinction coefﬁcient described
previously [15]. The concentrations of the other ligands were
determined by their molecular weights. All chemicals were of ana-
lytical grade.
2.2. Puriﬁcation of recombinant human L-PGDS
The open reading frame for human L-PGDS, which was com-
posed of 190 amino acid residues (GenBank accession No.
M61900) [32], was ligated into the BamHI-EcoRI sites of the
expression vector pGEX-2T (GE Healthcare Bio-Sciences). The N-
terminal 22-amino acid residues corresponding to the putative
secretion signal peptide of L-PGDS were truncated. C65A/C167A
(e280 = 25900 M1  cm1)-substituted L-PGDS was expressed in
Escherichia coli BL21 (DE3) (TOYOBO) [15]. Site-directed mutagen-
esis was performed using the QuikChange™ site-directed muta-
genesis kit (Stratagene). The mutated L-PGDS was expressed as a
glutathione S-transferase fusion protein. The fusion protein was
bound to glutathione–Sepharose 4B (GE Healthcare) and incubated
overnight with 165 units of thrombin to release L-PGDS. The re-
combinant proteins were further puriﬁed by gel ﬁltration chroma-
tography with HiLoad 16/600 Superdex 75 (GE Healthcare) in
5 mM Tris/HCl buffer (pH 8.0) and were then dialyzed against
50 mM Tris/HCl buffer (pH 8.0), 50 mM HEPES buffer (pH 8.0), or
50 mM sodium phosphate buffer (pH 8.0). In the present study,
the C65A/C167A-substituted L-PGDS was employed instead of
the wild-type protein, because the amount of the wild type is lim-
ited due to the incorrect intra- and intermolecular disulﬁde bonds
and protein aggregation.
2.3. Isothermal titration calorimetry
Calorimetric experiments were performed with a NanoITC
instrument (TA instruments) and VP-ITC instrument (MicroCal
Inc.) in 50 mM Tris/HCl buffer (pH 8.0), 50 mM HEPES buffer (pH
8.0), and 50 mM sodium phosphate buffer (pH 8.0) containing 5%
(v/v) DMSO at 25 C (Fig. 2 and Supplementary Figs. 1 and 2).
L-PGDS (120–1500 lM) in the injection syringe was titrated
into 69–86 lM hemin, 35–38 lM biliverdin, 39–41 lM bilirubin,
12–15 lM all-trans retinoic acid, 15–27 lM 9-cis retinoic acid,
24–30 lM T4, 30–40 lM T3, 30–80 lM progesterone, 40–80 lM
testosterone, 80 lM corticosterone, 30–40 lM genistein, 60–
65 lM naringenin, 60–65 lM daidzein, 35–40 lM U-46619, and
60–150 lM TNS, respectively. Titration experiments consisted of
25–58 injections spaced at intervals of 300–360 s. The injection
volume was 2 ll or 5 ll for each, and the cell was continuously
stirred at 270–351 rpm. The corresponding heat of dilution of L-
PGDS titrated to the buffer was used to correct the data. Observed
enthalpy changes (DHobs) for binding and the dissociation con-
stant (Kd) were directly calculated from the integrated heats using
the one-set of independent binding sites model supplied byMicroCal
Origin software. The equation of this binding model (Eq. (1)) was:
Q ¼ n½PtDH

obsV0
2
1þ LR
n
þ Kd
n½Pt

ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ LR
n
þ Kd
n½Pt
 2
 4LR
n
s2
4
3
5
ð1Þ
where Q is the change in heat in the system, V0 is the effective vol-
ume of the calorimeter cell (1.43 ml for the VP-ITC instrument and
0.17 ml for the NanoITC instrument), LR is the ratio of the total li-
gand concentration to total protein concentration ([P]t) at any given
Fig. 1. Structure of human L-PGDS and lipophilic ligands. (A) The three-dimensional structure of L-PGDS (PDB code: 3O2Y) [29] is shown. The secondary structure elements of
L-PGDS comprise nine b-strands (A–I) and four a-helices (H1, H2, H3 and H4). The hydrophobic and hydrophilic nature of the residues was shown in blue and red coloring,
respectively. The hydrophobic cavity is highlighted by the broken line. (B) Chemical structure and molecular mass (m) of small lipophilic molecules.
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ligand per protein molecule. Each binding site is assumed to show
the identical afﬁnity and enthalpy change. The thermodynamic
parameters for binding heme metabolites such as hemin, biliverdin,
and bilirubin with L-PGDS were evaluated using the two-set of
independent binding sites model supplied by MicroCal Origin 5.0
software. Using DHobs and Kd, the observed Gibbs energy change
for binding (DGobs) and the observed entropy change for binding
(DSobs) were obtained by the thermodynamic relationships (Eqs.
(2) and (3)) as follows;DG

obs ¼ RTlnKd ð2ÞDG

obs ¼ DH

obs  TDS

obs ð3Þ
where R is the gas constant and T is the temperature (298.15 K) in
Kelvin.
The experimentally observed enthalpy of binding contains both
the buffer-independent enthalpy change for binding (DHb) and
the enthalpy change associated with the ionization of the buffer
(DHi) [33]. DHobs is given as the sum of the above two contribu-
tions as expressed by the following equation:
DH

obs ¼ DH

b þ npro  DH

i ð4Þ
where npro is the number of protons exchanged between the pro-
tein–ligand complex and the bulk solution. The ionization enthalpy
Fig. 2. Calorimetric titration of small lipophilic ligands with L-PGDS in 50 mM Tris/HCl buffer at 25 C and pH 8.0. L-PGDS in the injection syringe was reversely titrated to
12 lM all-trans (A), 27 lM 9-cis retinoic acid (B), 30 lM T4 (C), 30 lM T3 (D), 30 lM progesterone (E), 80 lM testosterone (F), 80 lM corticosterone (G), 30 lM genistein (H),
65 lM naringenin (I), 60 lM daidzein (J), 35 lM U-46619 (K), and 60 lM TNS (L) in the cell, respectively. Thermograms and binding isotherms are shown in the upper and
lower panels, respectively. Solid lines in the lower panels are theoretical curves using Eq. (1).
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21.0 , and 3.52 kJ/mol, respectively [34]. The mean values of
apparent Kd (Kd–m) and DGobs (DGm) were calculated by using
the geometric mean and the arithmetic mean of those obtained in
the three buffers, respectively. The buffer-independent entropy
terms (–TDSb) were obtained by the thermodynamic relationships
(Eq. (3)) and the values of DGm and DHb. Values of R and p
between thermodynamic parameters (DGm, DHb, and –TDSb)
and hydrophobicity of each ligand were calculated by Pearson’s
product–moment correlation and a test of no correlation, respec-
tively (Fig. 3).3. Results
The thermodynamic characterization of intermolecular interac-
tions between C65A/C167A-substituted human L-PGDS and vari-
ous small lipophilic ligands at pH 8.0 and 25 C was performed
using ITC. We used 15 variations of lipophilic ligands including
heme metabolites (hemin, biliverdin, and bilirubin), retinoids
(all-trans and 9-cis retinoic acids), thyroids (T4 and T3), steroids
(progesterone, testosterone, and corticosterone), ﬂavonoids (genistein,naringenin, and daidzein), the substrate PGH2 analog U-46619, and
the ﬂuorescence probe TNS (Fig. 1B).
Relatively high concentrations of small molecules in the syringe
(several hundreds of micromoles to several millimoles) and low
concentrations of large molecules such as proteins (several tens
of micromoles) were generally required for ITC measurements.
Therefore, the low solubility of small hydrophobic ligands often
hampers ITC studies of intermolecular binding reactions. However,
by introducing the reverse titration of L-PGDS in the syringe to the
small lipophilic ligands in the cell, we succeeded in obtaining clear
thermograms and binding isotherms between L-PGDS and a series
of ligands in Tris/HCl buffer at pH 8.0 and 25 C (Fig. 2).
The titrations of L-PGDS to all-trans retinoic acid were accompa-
nied by negative peaks, which indicated that their binding reac-
tions were exothermic (Fig. 2A, upper panel). After integrating
each peak area, the integrated heat obtained for binding to retinoic
acid was plotted against the molar ratio ([L-PGDS]/[ligand])
(Fig. 2A, lower panel). The binding isotherm was ﬁtted using the
one-set of independent binding sites model (Eq. (1)), and produced
a Kd value of 1.01 ± 0.05 lM and 1:1 binding stoichiometry (n)
(Table 1). The binding reactions of the eleven other lipophilic
ligands to L-PGDS were then examined (Fig. 2B–L). Binding
Fig. 3. Correlation of binding thermodynamic parameters with the physico-
chemical properties of the ligands. Plotting of DGm (A), DHb (B) and –TDSb (C)
against the hydrophobicity of ligands (XlogP). The XlogP value of each ligand was
calculated using the ALOGPs program (version 2.1) [51]. (D) Correlation with DGm
values against the number of H bond acceptors of the ligand. Pearson’s correlation
coefﬁcient (R) and the p-values are shown.
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acid. The thermodynamic parameters obtained for complex forma-
tion were summarized in Table 1. Based on the n values, L-PGDSTable 1
Buffer-independent thermodynamic parameters of L-PGDS binding with small lipophilic l
Ligands XlogPb Sitec nd Kd (lM)e Kd–m
(lM)f
DGobs
(kJ/mol)e
Hemin 4.96 High 1.06a 0.003 ± 0.0004a 0.027 –48.4 ± 0.02a
Low 1.29a 0.2 ± 0.01a 0.55 –38.1 ± 0.01a
Biliverdin 3.77 High 1.01a 0.007 ± 0.0003a 0.009 –46.6 ± 0.1a
Low 1.00a 1.2 ± 0.02a 1.4 –33.8 ± 0.04a
Bilirubin 3.22 High 1.02a 0.02 ± 0.0007a 0.027 –44.2 ± 0.1a
Low 1.01a 1.6 ± 0.02a 1.8 –33.0 ± 0.03a
All-trans
retinoic acid
5.66 0.88 1.01 ± 0.05 1.7 –34.2 ± 0.1
9-cis Retinoic
acid
5.66 1.94 22.9 ± 0.9 9.2 –26.5 ± 0.1
T4 1.15 1.01 2.1 ± 0.05 4.6 –32.5 ± 0.1
T3 0.82 0.98 6.6 ± 0.2 13 –29.6 ± 0.1
Progesterone 3.58 1.94 14.9 ± 0.3 24 –27.6 ± 0.1
Testosterone 2.99 1.20 26.9 ± 1 28 –26.1 ± 0.1
Corticosterone 2.09 0.94 43.4 ± 3 82 –24.9 ± 0.2
Genistein 3.04 1.08 17.9 ± 0.3 21 –27.1 ± 0.04
Naringenin 2.47 1.06 8.7 ± 0.1 14 –28.9 ± 0.04
Daidzein 3.30 0.96 10.3 ± 0.1 30 –28.5 ± 0.02
U-46619 5.19 1.00 14.4 ± 0.3 14 –27.6 ± 0.05
TNS 2.01 3.03 16.3 ± 1 22 –27.3 ± 0.2
a Data were taken from our previous study [15].
b Hydrophobicity of each ligand calculated using the ALOGPs program [51].
c ‘‘High’’ and ‘‘Low’’ represent the binding sites with high and low afﬁnities, respectiv
d ‘‘n’’ signiﬁes the number of ligand molecules bound per a binding site.
e Observed binding thermodynamic parameters obtained in 50 mM Tris/HCl buffer (p
f Mean values of Kd (Kd–m).
g Mean values of DGobs (DGm).
h Values of the buffer-independent enthalpy change (DHb) obtained by linear regress
i Values of the buffer-independent entropy term (–TDSb).
j Number of protons exchanged between the protein–ligand complex and the bulk (nformed a 1:1 complex with all-trans retinoic acid, T4, T3, testoster-
one, corticosterone, genistein, naringenin, daidzein, and U-46619,
whereas L-PGDS showed 1:2 binding stoichiometry with 9-cis ret-
inoic acid and progesterone and 1:3 binding stoichiometry with
TNS (Table 1). The apparent Kd values of L-PGDS binding for the li-
gands ranged from 1.01 lM to 43.4 lM, which corresponded to
DGobs values from –24.9 kJ/mol to –34.2 kJ/mol (Table 1).
In order to eliminate buffer-dependent enthalpic contributions
from DHobs, we further performed ITC experiments for the 18 li-
gand-binding systems using HEPES and sodium phosphate buffers
(Supplementary Figs. 1 and 2). All binding reactions of L-PGDS with
the small lipophilic ligands in the HEPES and sodium phosphate
buffers were accompanied by exothermic reactions as in the case
of Tris/HCl buffer. The obtained thermodynamic parameters for
complex formation in Tris/HCl, HEPES, and sodium phosphate buf-
fers were summarized in Table 1 and Supplementary Table 1. The
values of DHobs were plotted against the ionization enthalpy of
each buffer. Then, the linear extrapolations of DHobs values were
performed using Eq. (4) to obtain npro andDHbwithout the contri-
bution of ionization enthalpy change (Supplementary Fig. 3). The
npro values for hemin, biliverdin, bilirubin, progesterone, testoster-
one, corticosterone, genistein, naringenin, daidzein, U-46619, and
TNS ranged from –0.3 to 0.2, suggesting that the contributions of
deprotonation and protonation from the buffer to DHobs are neg-
ligible (Table 1). However, the npro values of all-trans, 9-cis retinoic
acids, T4, and T3 were –0.6, –0.9, 1.0, and –0.9, respectively,
which indicated that DHobs contains a signiﬁcant contribution of
approximately one proton release from the complex on the binding
reaction (Table 1). The DHb values of all ligands examined here
ranged from –54.8 kJ/mol to –5.0 kJ/mol (Table 1), indicating that
negative DHb contributes favorably to the binding reactions of
L-PGDS with the small lipophilic ligands.
The values of Kd–m and DGm were calculated using those ob-
tained in the three distinct buffers (Table 1 and Supplementaryigands.
DGm
(kJ/mol)g
DHobs
(kJ/mol)e
DHb
(kJ/mol)h
–TDSobs
(kJ/mol)e
–TDSb
(kJ/mol)i
npro
j
–43.2 ± 6 –10.1 ± 0.04a –5.3 ± 1 –38.3 ± 0.04a –37.9 ± 6 –0.1
–35.8 ± 3 –14.8 ± 0.05a –22.0 ± 6 –23.3 ± 0.05a –13.8 ± 7 0.2
–45.9 ± 1 –12.6 ± 0.02a –13.2 ± 0.2 –34.0 ± 0.1a –32.7 ± 1 0.01
–33.4 ± 1 –23.9 ± 0.07a –24.3 ± 2 –9.9 ± 0.08a –9.1 ± 2 –0.004
–43.2 ± 1 –29.0 ± 0.04a –21.5 ± 7 –15.2 ± 0.1a –21.7 ± 7 –0.1
–32.8 ± 0.5 –52.0 ± 0.2a –47.9 ± 8 19.0 ± 0.2a 15.1 ± 8 –0.03
–32.9 ± 1 –38.8 ± 0.3 –5.8 ± 7 4.6 ± 0.3 –27.1 ± 7 –0.6
–28.7 ± 2 –51.7 ± 0.3 –5.0 ± 15 25.2 ± 0.3 –23.7 ± 15 –0.9
–30.5 ± 2 –63.8 ± 0.2 –15.6 ± 3 31.3 ± 0.2 –14.9 ± 4 –1
–27.8 ± 2 –62.3 ± 0.2 –16.6 ± 11 32.8 ± 0.3 –11.2 ± 11 –0.9
–26.4 ± 1 –25.2 ± 0.1 –27.4 ± 3 –2.4 ± 0.1 1.0 ± 3 0.1
–26.0 ± 0.5 –21.7 ± 0.2 –17.8 ± 4 –4.4 ± 0.3 –8.2 ± 4 –0.1
–23.3 ± 1 –15.5 ± 0.2 –22.0 ± 4 –9.4 ± 0.2 –1.3 ± 4 0.1
–26.7 ± 0.5 –54.3 ± 0.2 –38.9 ± 7 27.2 ± 0.2 12.2 ± 7 –0.3
–27.8 ± 1 –60.0 ± 0.1 –54.8 ± 3 31.1 ± 0.2 27.0 ± 3 –0.1
–25.8 ± 2 –32.1 ± 0.05 –40.8 ± 7 3.6 ± 0.05 15.0 ± 7 0.2
–27.7 ± 1 –19.1 ± 0.07 –13.6 ± 0.5 –8.5 ± 0.1 –14.1 ± 1 –0.1
–26.5 ± 0.7 –35.3 ± 0.5 –44.4 ± 7 8.0 ± 0.5 17.9 ± 7 0.1
ely.
H 8.0) containing 5% (v/v) DMSO.
ion of buffer contributions.
pro).
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of –TDSb using the thermodynamic relationships (Eq. (3)) and the
values ofDGm andDHb, 12 binding reactions out of 18 binding sys-
tems except for the low-afﬁnity site of bilirubin, progesterone, gen-
istein, naringenin, daidzein, and TNS showed the negative values of
–TDSb energetically favorable (Table 1). The –TDSb values for the
remaining 6 ligands ranged from1.0 kJ/mol to 27.0 kJ/mol. These re-
sults obviously demonstrated that the binding between L-PGDS and
the lipophilic ligands was driven by enthalpy regardless of the con-
tributions from the buffer ionization in the enthalpy change.
4. Discussion
DG values obtained from a number of binding systems that
mainly use intermolecular hydrophobic contacts have been ex-
plained by hydrophobic effects. These non-hydrophilic interactions
come from favorable entropy, with increases in translational or
cratic entropy due to dehydrated water molecules. For example,
Olsson et al. reported that DG linearly correlated with reductions
in the hydrated apolar surface area upon the complexation of glob-
ular proteins and small ligands using approximately 60 binding
systems [35]. They suggested that the contribution of apolar
desolvation to the DG values may be attributed to gains in dehy-
dration entropy. Lipinski et al. also reported that an improvement
in drug candidates for target proteins could be obtained by increas-
ing hydrophobicity on the basis of water dehydration [36,37]. We
previously reported that the protein–protein complex was stabi-
lized by both the dehydration entropy from the surfaces of protein
and the conformational entropy of protein upon the binding [2].
Thus, one of the main thermodynamic driving forces in binding
is the gain in entropy from interface desolvation of proteins and
their binding partners. In contrast, there are thermodynamic bind-
ing studies supporting the idea that a favorable enthalpic term is
convenient for afﬁnity optimization or selectivity optimization
purposes [38], because the contribution of binding enthalpy is
more difﬁcult to engineer and improve than that of binding entro-
py. Also, increasing electrostatic networks by trapping water be-
tween binding molecules was shown to be proportional to high
binding afﬁnity (lower DG) due to favorable enthalpy changes
[39]. As we described previously, DG is an outcome of the balance
between DH and DS. Therefore, although one of the two driving
forces is apparently dominant, binding energetics should be con-
sidered by both enthalpy and entropy.
Apparent hydrophobic interactions between the hydrophobic
cavity of lipocalins and lipophilic ligands were demonstrated by
the crystal structures of L-PGDS:oleic acid complex, L-PGDS:pal-
mitoleic acid complex [29], and b-latoglobulin:12-bromododeca-
noic acid complex [40], and several ﬂuorescence measurements
[15,41]. These studies provide a biased view regarding the entropic
gain of hydrophobic effects between L-PGDS and lipophilic ligands.
However, as was clearly shown by the present ITC study, the com-
plex formation of L-PGDS and lipophilic ligands was not always
driven by entropy regardless of the contributions from the buffer
in the enthalpy change. The favorable gains in –TDSb were ob-
served in 12 kinds of binding systems such as hemin, biliverdin,
the high-afﬁnity site for bilirubin, all-trans retinoic acid, 9-cis reti-
noic acid, T4, T3, testosterone, corticosterone and U-46619,
whereas all binding reactions of L-PGDS with the small lipophilic
ligands were enthalpically favored (Table 1). A similar enthalpy-
driven process was also observed in binding of the hydrophobic
cavity of major urinary protein and pyrazine derivatives [9].
Weak correlation was observed between the values ofDGm and
the hydrophobicity of ligands (Fig. 3A, R = –0.34, p = 0.17), whereas
the increasing hydrophobicity of ligands leads to less favorable
enthalpy (Fig. 3B, R = 0.44, p = 0.07) and more favorable entropy
(Fig. 3C, R = –0.48, p = 0.04). This tendency in enthalpy and entropysuggested an agreement with the expected trend in classical
hydrophobic interactions. Interestingly, we revealed that DGm
values corresponding to the mean binding afﬁnities showed a
strong negative correlation with the number of hydrogen bond
acceptors of lipophilic ligands (Fig. 3D, R = –0.67, p < 0.01), which
suggested the formation of intermolecular hydrogen bonds be-
tween L-PGDS and lipophilic ligands. These results indicated that
favorable enthalpic gains such as hydrogen bonding contribute to
stabilize the formation of complexes between L-PGDS and lipo-
philic ligands in addition to the hydrophobic effects attributed to
water dehydrations. It is also worth noting that the reorganization
of water molecules during the binding process between hydropho-
bic molecules indirectly gained enthalpy, i.e., the enthalpy-driven
hydrophobic effect [42,43]. In the binding of the proline-rich pep-
tides to the Src homology 3 domain, the establishment of an intri-
cate network of water-mediated hydrogen bonds was reported to
contribute substantially to the extremely negative binding enthal-
py (92 kJ/mol) [44,45]. On the other hand, the hydrophobic asso-
ciation of lipophilic ligands to mouse urinary protein in the
solution is characterized by a reduced desolvation due to an
incomplete solvation of the ligand-binding pocket [9,46,47]. These
results may relate to the abnormal enthalpic gains from the in-
creases in favorable electrostatic interactions among water mole-
cules and main/side chains of proteins.
Although there are several complex structures between L-PGDS
and ligands, the crystal structures of human L-PGDS complexed
with fatty acids (oleic acid and palmitic acid, code: 3O19, 3O22,
3O2Y) [29], substrate analog U-44069 (code: 4IMO) [28], and the
solution structure of mouse L-PGDS complexed with substrate ana-
log U-46619 (code: 2KTD), the only available information on the
complex structure between L-PGDS and the lipophilic ligand uti-
lized here is the complex of mouse L-PGDS and U-46619. It is as-
sumed that human L-PGDS examined in the present study show
a similar thermodynamic behaviors for binding U-46619 to mouse
L-PGDS on the basis of 75–80% sequence homology between the
two L-PGDSs. Changes in the accessible surface area (DASA) on
the intermolecular interactions between mouse L-PGDS and U-
46619 were calculated using the complex structure (code 2KTD)
together with the LigPlot visualization [48]. The values of DASA
were assessed to be 96.9 Å2 for polar surfaces and 328.6 Å2 for apo-
lar surfaces using the Structural Thermodynamics Calculations
software [49]. The LigPlot diagram of mouse L-PGDS with U-
46619 showed the participation of 13 residues (Ser45, Leu48,
Lys58, Leu62, Tyr63, Cys65, Thr67, Glu90, Met94, Tyr107, Ser109,
Pro110, and His116) in the hydrophobic interactions and a hydro-
gen bond between the Ser81 residue and U-46619 (Supplementary
Fig. 4). These results indicated that intermolecular interactions
were dominated by the hydrophobic effect due to the contacts
among hydrophobic surfaces, suggesting that the binding is entro-
py-driven. However, a moderate binding afﬁnity of human L-PGDS
for U-46619 is attributed to almost equal favorable enthalpic and
entropic contributions, suggesting the consequence of the enthal-
pic contribution on the L-PGDS/U-46619 binding, which estimated
by direct thermodynamic characterization in solution using calo-
rimetry. Thus, it would be necessary to address the origin of bind-
ing enthalpy in L-PGDS and the lipophilic ligands by using the
molecular dynamic simulation, X-ray crystallography, and the
solution-state NMR spectroscopy coupled with the hydrogen/deu-
terium exchange method.
A comprehensive driving force plot for the 18 binding systems
was constructed to better understand the interplay between en-
thalpy and entropy for the wide range of binding capabilities of
L-PGDS (Fig. 4). DGm values were mainly around –30 kJ/mol and
all binding systems were enthalpically favorable. Among them, 6
binding systems were assigned to a purely enthalpy-driven region
(I), and 6 (II) and 6 (III) binding systems were assigned to mainly
Fig. 4. Buffer-independent comprehensive driving force plot. The buffer-indepen-
dent binding thermodynamic parameters (DHb and –TDSb) for each complex
formation were plotted. The driving forces for binding were classiﬁed by the purely
DH-driven region (upper left region), enthalpy/entropy-driven region (lower left),
and purely DS-driven region (lower right). The four black dashed lines indicate
DGm values (–15, –30, –45, and –60 kJ/mol). The blue dashed line indicates the
border of the more dominant driving force between enthalpy and entropy.
968 S. Kume et al. / FEBS Letters 588 (2014) 962–969enthalpy- and entropy-driven formation, respectively. No purely
entropy-driven formation was noted (region IV). Plotting individ-
ual driving forces also showed enthalpy–entropy compensation
(R = –0.94 and p < 0.01). This balance was explained by enthalpic
gains being predominantly obtained by electrostatic interactions
such as the formation of hydrogen bonds and/or van der Waals’
interactions being compensated by an enthalpic penalty of dehy-
dration and a loss of conformational entropy [6,35,50], and was
further balanced by entropic gains of the hydrophobic effect. Thus,
binding afﬁnity depends on the degree of compensation of enthal-
py gains: small compensation leads to high binding afﬁnity,
whereas large compensation decreases the binding afﬁnity. The
hydrophobic effect may compromise the compensation of enthal-
pic gains as suggested in the opposite correlation of DHb and
TDSb against hydrophobicity (Fig. 3B and C). L-PGDS may use
this enthalpy–entropy compensation to have a broad capability
for ligand binding.
In conclusion, we propose that intermolecular interactions be-
tween L-PGDS and lipophilic ligands should also be viewed as
hydrophilic interactions, and the broad binding capability of L-
PGDS with various ligands is delicately tuned by enthalpy–entropy
compensation using hydrophilic and hydrophobic interactions.
These systematic thermodynamic studies based on ITC measure-
ments will be helpful in developing drug delivery systems for
poorly water-soluble compounds using L-PGDS. The comprehen-
sive driving force plot will also be useful for better understanding
the molecular origins of intermolecular interactions.
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